| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.29 | 0.06 |